Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:protein
gptkb:drug |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 1996 |
| gptkbp:ATCCode |
B01AD07
|
| gptkbp:brand |
Retavase
|
| gptkbp:CASNumber |
173146-27-5
|
| gptkbp:contraindication |
active internal bleeding
history of stroke |
| gptkbp:developedBy |
gptkb:Boehringer_Ingelheim
|
| gptkbp:drugClass |
gptkb:tissue_plasminogen_activator
|
| https://www.w3.org/2000/01/rdf-schema#label |
Reteplase
|
| gptkbp:indication |
ST-elevation myocardial infarction
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
gptkb:plasminogen_activator
fibrinolytic |
| gptkbp:molecularWeight |
39 kDa
|
| gptkbp:proteinOrigin |
gptkb:Bacteria
|
| gptkbp:relatedTo |
gptkb:alteplase
gptkb:tenecteplase |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
bleeding
allergic reaction |
| gptkbp:target |
gptkb:fibrin
gptkb:plasminogen |
| gptkbp:UNII |
Q1J8A2JZ4B
|
| gptkbp:usedFor |
gptkb:acute_myocardial_infarction
|
| gptkbp:bfsParent |
gptkb:Thrombolytics
|
| gptkbp:bfsLayer |
7
|